|
Welcome back Rounds Table Listeners!
We are back today with an oldie but a goodie!
In this repeat episode, Mike and John do a Rapid Fire session to discuss two recent papers exploring the cardiovascular and renal benefits of two medications used in the management of diabetes. Two papers, here we go!
- Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF (0:00 – 6:58).
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes (6:58 – 13:35).
And for the Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable
The post Episode 30 – SGLT2 inhibitors and GLP-1 agonists in Diabetes (Repeat) appeared first on Healthy Debate. |